open-house-model" in the period from 04/15/2016 to 03/31/2018 for medicinal products for drug combination eprosartan
/ hydrochlorothiazide (atc code who: c09da02, official atc code: c09da22).
may be associated with rare instances of hepatotoxicity that typically occurs within 2-16 weeks of therapy.
We are aware of only 5 case reports in which patients developed severe enteropathy while taking irbesartan (2 cases), (11, 24) valsartan, (25) telmisartan, or eprosartan
(only abstract available for review in English).
Common ARBs used to manage HTN include azilsartan (Edarbi[R]), candesartan (Atacand[R]), eprosartan
(Teveten[R]), irbesartan (Avapro[R]), losartan (Cozaar[R]), olmesartan (Benicar[R]), telmisartan (Micardis[R]), and valsartan (Diovan[R]).
Since then several others have been synthesized including valsartan irbesartan tel-misartan candesartan eprosartan
Effects of hypertension therapy based on eprosartan
on systolic arterial blood pressure and cognitive function: primary results of the observational study on cognitive function and systolic blood pressure reduction open label study.
Some commonly prescribed drugs in this class are candesartan (Atacand), eprosartan
(Teveten), irbesarten (Avapro), losartan (Cozaar), telmisartan (Micardis) and valsartan (Diovan).
TYPES AND FUNCTIONS OF BLOOD PRESSURE DRUGS TYPE GENERIC NAME FUNCTION (BRAND NAME) Diuretics Furosemide Help rid the body of (Lasix) excess sodium and water Chlorthalidone (Hygroton) Beta blockers Acebutolol Reduce the heart rate, (Sectral) the heart's workload and its output of blood Atenolol (Tenormin) Betaxolol (Kerlone) Angiotensin-converting Ramipril Help reduce the enzyme (ACE) inhibitors (Altace) production of angiotensin, which causes blood vessels to narrow Benazepril hydrochloride (Lotensin) Angiotensin II receptor Irbesarten Help prevent the blockers (ARBs) (Avapro) receptors in blood vessels from binding with angiotensin Eprosartan
mesylate (Teveten) Valsartan (Diovan)
Morbidity and mortality after stroke eprosartan
compared compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).
28 December 2011 - US generic and specialty pharmaceutical major Mylan Inc (NASDAQ:MYL) said on Tuesday its Mylan Pharmaceuticals Inc unit had obtained final US Food and Drug Administration (FDA) approval for its ANDA for Eprosartan
Mesylate Tablets, 400 mg (base) and 600 mg (base), the generic version of Abbott's (NYSE:ABT) hypertension treatment Teveten Tablets.
There are seven single-ingredient ARBs approved by the FDA for treating hypertension: candesartan (Atacand), irbesartan (Avapro), olmesartan (Benicar), losartan (Cozaar), valsartan (Diovan), telmisartan (Micardis), and eprosartan
The key words used for search were: congestive heart failure, chronic heart failure, heart failure, left ventricular systolic dysfunction, Angiotensin converting enzyme inhibitors, angiotensin- II receptor blockers, angiotensin receptor blockers, combination angiotensin converting enzyme inhibitors and angiotensin- II receptor blockers (or angiotensin receptor blockers) and the following generic names of individual agents in current practice: candesartan, eprosartan
, irbesartan, losartan, tasosartan, telmisartan, and valsartan.